Cell-based therapies for experimental chronic kidney disease: A systematic review and meta-analysis

DMM Disease Models and Mechanisms

Volumn 8, Issue 3, 2015, Pages 281-293

  Papazova, Diana A ^a   Oosterhuis, Nynke R ^a   Gremmels, Hendrik ^a   Van Koppen, Arianne ^a   Joles, Jaap A ^a   Verhaar, Marianne C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cell based therapy; Chronic kidney disease; Meta analysis

Indexed keywords

CREATININE; UREA;

BLOOD PRESSURE; BONE MARROW CELL; CELL THERAPY; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; MESENCHYMAL STROMA CELL; META ANALYSIS; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UREA BLOOD LEVEL; ANIMAL; BIOLOGICAL THERAPY; BLOOD; COMPLICATION; DISEASE MODEL; KIDNEY; METABOLISM; OUTCOME ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; PROTEINURIA; PUBLISHING; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC;

ANIMALIA;

ANIMALS; BLOOD PRESSURE; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; KIDNEY; OUTCOME ASSESSMENT (HEALTH CARE); PROTEINURIA; PUBLICATION BIAS; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; UREA;

EID: 84929174218     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.017699     Document Type: Review

References (93)

1. Alexandre, C. S., Volpini, R. A., Shimizu, M. H., Sanches, T. R., Semedo, P., di Jura, V. L., Câmara, N. O., Seguro, A. C. and Andrade, L. (2009). Lineage-negative bone marrow cells protect against chronic renal failure. Stem Cells 27, 682-692.
2. Alfarano, C., Roubeix, C., Chaaya, R., Ceccaldi, C., Calise, D., Mias, C., Cussac, D., Bascands, J. L. and Parini, A. (2012). Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats. Cell Transplant. 21, 2009-2019.
3. Bian, X., Zhang, B., Guo, W., Liu, N., Bai, Y., Miao, J., Zhao, G., Liu, B., Wang, S., Ma, L. et al. (2014). Effects of mesenchymal stem cells transplanted at different time points in a rat remnant kidney model. Am. J. Nephrol. 39, 75-84.
4. Bohle, A., Müller, G. A., Wehrmann, M., Mackensen-Haen, S. and Xiao, J. C. (1996). Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int. Suppl. 54, S2-S9.
5. Caldas, H. C., Fernandes, I. M. M., Gerbi, F., Souza, A. C., Baptista, M. A. S. F., Ramalho, H. J., Kawasaki-Oyama, R. S., Goloni-Bertollo, E. M., Pavarino-Bertelli, E. C., Braile, D. M. et al. (2008). Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure. Transplant. Proc. 40, 853-855.
6. Caldas, H. C., Fernandes, I. M. M., Kawasaki-Oyama, R. S., Baptista, M. A. S. F., Plepis, A. M. G., Martins, V. A., Coimbra, T. M., Goloni-Bertollo, E. M., Braile, D. M. and Abbud-Filho, M. (2011). Effect of stem cells seeded onto biomaterial on the progression of experimental chronic kidney disease. Exp. Biol. Med. 236, 746-754.
7. Cantaluppi, V., Biancone, L., Quercia, A., Deregibus, M. C., Segoloni, G. and Camussi, G. (2013). Rationale of mesenchymal stem cell therapy in kidney injury. Am. J. Kidney Dis. 61, 300-309.
8. Cao, Q., Wang, Y., Zheng, D., Sun, Y., Wang, C., Wang, X. M., Lee, V. W. S., Wang, Y., Zheng, G., Tan, T. K., et al. (2014). Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivo. Kidney International 85, 794-806.
9. Castiglione, R. C., Maron-Gutierrez, T., Barbosa, C. M. L., Ornellas, F. M., Barreira, A. L., Dibarros, C. B. A., Vasconcelos-dos-Santos, A., Paredes, B. D., Pascarelli, B. M., Diaz, B. L. et al. (2013). Bone marrow-derived mononuclear cells promote improvement in glomerular function in rats with early diabetic nephropathy. Cell. Physiol. Biochem. 32, 699-718.
10. Cavaglieri, R. C., Martini, D., Sogayar, M. C. and Noronha, I. L. (2009). Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant. Proc. 41, 947-951.
11. Chade, A. R., Zhu, X., Lavi, R., Krier, J. D., Pislaru, S., Simari, R. D., Napoli, C., Lerman, A. and Lerman, L. O. (2009). Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 119, 547-557.
12. Chade, A. R., Zhu, X.-Y., Krier, J. D., Jordan, K. L., Textor, S. C., Grande, J. P., Lerman, A. and Lerman, L. O. (2010). Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 28, 1039-1047.
13. Challen, G. A., Bertoncello, I., Deane, J. A., Ricardo, S. D. and Little, M. H. (2006). Kidney side population reveals multilineage potential and renal functional capacity but also cellular heterogeneity. J. Am. Soc. Nephrol. 17, 1896-1912.
14. Chang, J.-W., Hung, S.-P., Wu, H.-H., Wu, W.-M., Yang, A.-H., Tsai, H.-L., Yang, L.-Y. and Lee, O. K. (2011). Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant. 20, 245-257.
15. Chang, J.-W., Tsai, H.-L., Chen, C.-W., Yang, H.-W., Yang, A.-H., Yang, L.-Y., Wang, P. S., Ng, Y.-Y., Lin, T.-L. and Lee, O. K. (2012). Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation. J. Cell. Mol. Med. 16, 2935-2949.
16. Chen, J., Li, H., Addabbo, F., Zhang, F., Pelger, E., Patschan, D., Park, H.-C., Kuo, M.-C., Ni, J., Gobe, G. et al. (2009). Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence. Am. J. Pathol. 174, 701-711.
17. Choi, S., Park, M., Kim, J., Hwang, S., Park, S. and Lee, Y. (2009). The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev. 18, 521-530.
18. Choi, S. J., Kim, J. K. and Hwang, S. D. (2010). Mesenchymal stem cell therapy for chronic renal failure. Expert Opin. Biol. Ther. 10, 1217-1226.
19. Chung, B. H., Lim, S. W., Doh, K. C., Piao, S. G., Heo, S. B. and Yang, C. W. (2013). Human adipose tissue derived mesenchymal stem cells aggravate chronic cyclosporin nephrotoxicity by the induction of oxidative stress. PLoS ONE 8, e59693.
20. De Chiara, L., Fagoonee, S., Ranghino, A., Bruno, S., Camussi, G., Tolosano, E., Silengo, L. and Altruda, F. (2014). Renal cells from spermatogonial germline stem cells protect against kidney injury. J. Am. Soc. Nephrol. 25, 316-328.
21. Donizetti-Oliveira, C., Semedo, P., Burgos-Silva, M., Cenedeze, M. A., Malheiros, D. M. A. C., Reis, M. A., Pacheco-Silva, A. and Câmara, N. O. S. (2012). Adipose tissue-derived stem cell treatment prevents renal disease progression. Cell Transplant. 21, 1727-1741.
22. Du, T., Zou, X., Cheng, J., Wu, S., Zhong, L., Ju, G., Zhu, J., Liu, G., Zhu, Y. and Xia, S. (2013). Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells. Stem Cell Research & Therapy 4, 59.
23. Duval, S. and Tweedie, R. (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455-463.
24. Ebrahimi, B., Li, Z., Eirin, A., Zhu, X. Y., Textor, S. C. and Lerman, L. O. (2012). Addition of endothelial progenitor cells to renal revascularization restores medullary tubular oxygen consumption in swine renal artery stenosis. Am. J. Physiol. 302, F1478-F1485.
25. Eirin, A., Zhu, X.-Y., Krier, J. D., Tang, H., Jordan, K. L., Grande, J. P., Lerman, A., Textor, S. C. and Lerman, L. O. (2012). Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells 30, 1030-1041.
26. Eirin, A., Zhu, X. Y., Li, Z., Ebrahimi, B., Zhang, X., Tang, H., Korsmo, M. J., Chade, A. R., Grande, J. P., Ward, C. J. et al. (2013). Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis. Arterioscler. Thromb. Vasc. Biol. 33, 1006-1013.
27. Eirin, A., Zhang, X., Zhu, X. Y., Tang, H., Jordan, K. L., Grande, J. P., Dietz, A. B., Lerman, A., Textor, S. C. and Lerman, L. O. (2014). Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis. Nephrol. Dial. Transplant. 29, 274-282.
28. Ezquer, F., Ezquer, M., Simon, V., Pardo, F., Yañez, A., Carpio, D. and Conget, P. (2009). Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice. Biol. Blood Marrow Transplant. 15, 1354-1365.
29. Fang, Y., Tian, X., Bai, S., Fan, J., Hou, W., Tong, H. and Li, D. (2012). Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress, pro-inflammatory cytokines and the p38 MAPK signaling pathway. Int. J. Mol. Med. 30, 85-92.
30. Fischer, U. M., Harting, M. T., Jimenez, F., Monzon-Posadas, W. O., Xue, H., Savitz, S. I., Laine, G. A. and Cox, C. S., Jr (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 18, 683-692.
31. Franquesa, M., Herrero, E., Torras, J., Ripoll, E., Flaquer, M., Gomà, M., Lloberas, N., Anegon, I., Cruzado, J. M., Grinyó, J. M. et al. (2012). Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev. 21, 3125-3135.
32. Furuhashi, K., Tsuboi, N., Shimizu, A., Katsuno, T., Kim, H., Saka, Y., Ozaki, T., Sado, Y., Imai, E., Matsuo, S. et al. (2013). Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages. J. Am. Soc. Nephrol. 24, 587-603.
33. Gatti, S., Bruno, S., Deregibus, M. C., Sordi, A., Cantaluppi, V., Tetta, C. and Camussi, G. (2011). Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol. Dial. Transplant. 26, 1474-1483.
34. Gremmels, H., Teraa, M., Quax, P. H., den Ouden, K., Fledderus, J. O. and Verhaar, M. C. (2014). Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls. Mol. Ther. 22, 1960-1970.
35. Griffin, K. A., Picken, M. M. and Bidani, A. K. (2004). Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat. Kidney Int. 65, 209-218.
36. Gu, Z., Akiyama, K., Ma, X., Zhang, H., Feng, X., Yao, G., Hou, Y., Lu, L., Gilkeson, G. S., Silver, R. M. et al. (2010). Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus 19, 1502-1514.
37. Guo, J., Zou, Y., Wu, Z., Wu, W., Xu, Z., Hu, H., Huang, L., Dong, H., Chen, J., Lu, J. et al. (2014). Protective effects of mesenchymal stromal cells on adriamycin-induced minimal change nephrotic syndrome in rats and possible mechanisms. Cytotherapy 16, 471-484.
38. Harrison, F., Yeagy, B. A., Rocca, C. J., Kohn, D. B., Salomon, D. R. and Cherqui, S. (2013). Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis. Mol. Ther. 21, 433-444.
39. He, J., Wang, Y., Sun, S., Yu, M., Wang, C., Pei, X., Zhu, B., Wu, J. and Zhao, W. (2012). Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model. Nephrology (Carlton) 17, 493-500.
40. Higgins, J. P. T., Thompson, S. G., Deeks, J. J. and Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ 327, 557-560.
41. Hooijmans, C. R., Tillema, A., Leenaars, M. and Ritskes-Hoitinga, M. (2010). Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMed. Lab. Anim. 44, 170-175.
42. Huang, Z.-Y., Hong, L.-Q., Na, N., Luo, Y., Miao, B. and Chen, J. (2012). Infusion of mesenchymal stem cells overexpressing GDNF ameliorates renal function in nephrotoxic serum nephritis. Cell Biochem. Funct. 30, 139-144.
43. Hyun, Y. Y., Kim, I. O., Kim, M. H., Nam, D. H., Lee, M. H., Kim, J. E., Song, H. K., Cha, J. J., Kang, Y. S., Lee, J. E. et al. (2012). Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy. Cell Transplant. 21, 2425-2439.
44. Jiao, Y.-Q., Yi, Z.-W., He, X.-J., Liu, X.-H., He, Q.-N. and Huang, D.-L. (2011). Does injection of metanephric mesenchymal cells improve renal function in rats? Saudi J. Kidney Dis. Transpl. 22, 501-510.
45. Khwaja, A., El Kossi, M., Floege, J. and El Nahas, M. (2007). The management of CKD: a look into the future. Kidney Int. 72, 1316-1323.
46. Klinkhammer, B. M., Kramann, R., Mallau, M., Makowska, A., van Roeyen, C. R., Rong, S., Buecher, E. B., Boor, P., Kovacova, K., Zok, S. et al. (2014). Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential. PLoS ONE 9, e92115.
47. Kramann, R., Couson, S. K., Neuss, S., Kunter, U., Bovi, M., Bornemann, J., Knüchel, R., Jahnen-Dechent, W., Floege, J. and Schneider, R. K. (2011). Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells. Arterioscler. Thromb. Vasc. Biol. 31, e45-e54.
48. Kunter, U., Rong, S., Boor, P., Eitner, F., Müller-Newen, G., Djuric, Z., van Roeyen, C. R., Konieczny, A., Ostendorf, T., Villa, L. et al. (2007). Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J. Am. Soc. Nephrol. 18, 1754-1764.
49. Lalu, M. M., McIntyre, L., Pugliese, C., Fergusson, D., Winston, B. W., Marshall, J. C., Granton, J., Stewart, D. J.; Canadian Critical Care Trials Group (2012). Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS ONE 7, e47559.
50. Lee, S.-R., Lee, S.-H., Moon, J.-Y., Park, J.-Y., Lee, D., Lim, S. J., Jeong, K.-H., Park, J.-K., Lee, T.-W. and Ihm, C.-G. (2010). Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model. Ren. Fail. 32, 840-848.
51. Li, K., Han, Q., Yan, X., Liao, L. and Zhao, R. C. (2010). Not a process of simple vicariousness, the differentiation of human adipose-derived mesenchymal stem cells to renal tubular epithelial cells plays an important role in acute kidney injury repairing. Stem Cells Dev. 19, 1267-1275.
52. Li, W., Jiang, H. and Feng, J.-M. (2012). Isogenic mesenchymal stem cells transplantation improves a rat model of chronic aristolochic acid nephropathy via upregulation of hepatic growth factor and downregulation of transforming growth factor β1. Mol. Cell. Biochem. 368, 137-145.
53. Lv, S.-S., Liu, G., Wang, J.-P., Wang, W.-W., Cheng, J., Sun, A.-L., Liu, H.-Y., Nie, H.-B., Su, M.-R. and Guan, G.-J. (2013). Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration. Int. Immunopharmacol. 17, 275-282.
54. Ma, H., Wu, Y., Xu, Y., Sun, L. and Zhang, X. (2013a). Human umbilical mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis. Am. J. Med. Sci. 346, 486-493.
55. Ma, H., Wu, Y., Zhang, W., Dai, Y., Li, F., Xu, Y., Wang, Y., Tu, H., Li, W. and Zhang, X. (2013b). The effect of mesenchymal stromal cells on doxorubicin-induced nephropathy in rats. Cytotherapy 15, 703-711.
56. Masoad, R. E., Ewais, M. M. S., Tawfik, M. K. and Abd El-All, H. S. (2012). Effect of mononuclear cells versus pioglitazone on streptozotocin-induced diabetic nephropathy in rats. Pharmacol. Rep. 64, 1223-1233.
57. Ninichuk, V., Gross, O., Segerer, S., Hoffmann, R., Radomska, E., Buchstaller, A., Huss, R., Akis, N., Schlöndorff, D. and Anders, H.-J. (2006). Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int. 70, 121-129.
58. Noh, H., Yu, M. R., Kim, H. J., Jeon, J. S., Kwon, S. H., Jin, S. Y., Lee, J., Jang, J., Park, J. O., Ziyadeh, F. et al. (2012). Uremia induces functional incompetence of bone marrow-derived stromal cells. Nephrol. Dial. Transplant. 27, 218-225.
59. Nur, R., Fukuda, N., Matsumoto, T., Medet, J., Kano, K., Yamamoto, C., Maruyama, T., Endo, M. and Matsumoto, K. (2008). Implantation of dedifferentiated fat cells ameliorates habu snake venom-induced chronic renal dysfunction in tenascin-C-deficient mice. Nephron Exp. Nephrol. 110, e91-e98.
60. Oliveira-Sales, E. B., Maquigussa, E., Semedo, P., Pereira, L. G., Ferreira, V. M., Câmara, N. O., Bergamaschi, C. T., Campos, R. R. and Boim, M. A. (2013). Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture. PLoS ONE 8, e78464.
61. Park, J. H., Hwang, I., Hwang, S. H., Han, H. and Ha, H. (2012a). Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action. Diabetes Res. Clin. Pract. 98, 465-473.
62. Park, J. H., Park, J., Hwang, S. H., Han, H. and Ha, H. (2012b). Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury. Transplant. Proc. 44, 1123-1126.
63. Ratliff, B. B., Ghaly, T., Brudnicki, P., Yasuda, K., Rajdev, M., Bank, M., Mares, J., Hatzopoulos, A. K. and Goligorsky, M. S. (2010). Endothelial progenitors encapsulated in bioartificial niches are insulated from systemic cytotoxicity and are angiogenesis competent. Am. J. Physiol. 299, F178-F186.
64. Reinders, M. E. J., de Fijter, J. W., Roelofs, H., Bajema, I. M., de Vries, D. K., Schaapherder, A. F., Claas, F. H. J., van Miert, P. P. M. C., Roelen, D. L., van Kooten, C. et al. (2013a). Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl. Med. 2, 107-111.
65. Reinders, M. E. J., Roemeling-van Rhijn, M., Khairoun, M., Lievers, E., de Vries, D. K., Schaapherder, A. F. M., Wong, S. W. S., Zwaginga, J. J., Duijs, J. M., van Zonneveld, A. J. et al. (2013b). Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy. Cytotherapy 15, 663-672.
66. Roemeling-van Rhijn, M., Reinders, M. E. J., de Klein, A., Douben, H., Korevaar, S. S., Mensah, F. K. F., Dor, F. J. M. F., IJzermans, J. N. M., Betjes, M. G. H., Baan, C. C. et al. (2012). Mesenchymal stem cells derived from adipose tissue are not affected by renal disease. Kidney Int. 82, 748-758.
67. Sangidorj, O., Yang, S. H., Jang, H. R., Lee, J. P., Cha, R. H., Kim, S. M., Lim, C. S. and Kim, Y. S. (2010). Bone marrow-derived endothelial progenitor cells confer renal protection in a murine chronic renal failure model. Am. J. Physiol. 299, F325-F335.
68. Sarafidis, P. A. and Ruilope, L. M. (2014). Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation? Kidney Int. 85, 536-546.
69. Semedo, P., Correa-Costa, M., Cenedeze, M. A., Malheiros, D. M. A. C., Antonia dos Reis, M., Shimizu, M. H., Seguro, A. C., Pacheco-Silva, A. and Câmara, N. O. S. (2009). Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 27, 3063-3073.
70. Shuai, L., Li, X., He, Q., Dang, X., Chen, H., Zhou, P., Yi, Z. and He, X. (2012). Angiogenic effect of endothelial progenitor cells transfected with telomerase reverse transcriptase on peritubular microvessel in five out of six subtotal nephrectomy rats. Ren. Fail. 34, 1270-1280.
71. Sterne, J. A. C. and Egger, M. (2005). Regression methods to detect publication and other bias in meta-analysis. In Publication bias in meta-analysis: Prevention, assessment, and adjustments. H. R. Rothstein, A. J. Sutton and M. Borenstein (Eds.), pp. 99-110. Chichester, UK: Wiley.
72. Tan, J., Wu, W., Xu, X., Liao, L., Zheng, F., Messinger, S., Sun, X., Chen, J., Yang, S., Cai, J. et al. (2012). Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 307, 1169-1177.
73. Tögel, F. E. and Westenfelder, C. (2012). Kidney protection and regeneration following acute injury: progress through stem cell therapy. Am. J. Kidney Dis. 60, 1012-1022.
74. Tögel, F., Cohen, A., Zhang, P., Yang, Y., Hu, Z. and Westenfelder, C. (2009). Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev. 18, 475-486.
75. Urbieta-Caceres, V. H., Zhu, X.-Y., Jordan, K. L., Tang, H., Textor, K., Lerman, A. and Lerman, L. O. (2012). Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease. Atherosclerosis 221, 350-358.
76. van der Spoel, T. I. G., Jansen of Lorkeers, S. J., Agostoni, P., van Belle, E., Gyöngyösi, M., Sluijter, J. P., Cramer, M. J., Doevendans, P. A. and Chamuleau, S. A. (2011). Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovasc. Res. 91, 649-658.
77. van Koppen, A., Joles, J. A., Bongartz, L. G., van den Brandt, J., Reichardt, H. M., Goldschmeding, R., Nguyen, T. Q. and Verhaar, M. C. (2012a). Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease. Cell Transplant. 21, 2299-2312.
78. van Koppen, A., Joles, J. A., van Balkom, B. W. M., Lim, S. K., de Kleijn, D., Giles, R. H. and Verhaar, M. C. (2012b). Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS ONE 7, e38746.
79. Vesterinen, H. M., Sena, E. S., Egan, K. J., Hirst, T. C., Churolov, L., Currie, G. L., Antonic, A., Howells, D. W. and Macleod, M. R. (2014). Meta-analysis of data from animal studies: a practical guide. J. Neurosci. Methods 221, 92-102.
80. Viechtbauer, W. (2010). Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 36, 1-48.
81. Villanueva, S., Ewertz, E., Carrión, F., Tapia, A., Vergara, C., Céspedes, C., Sáez, P. J., Luz, P., Irarrázabal, C., Carreño, J. E. et al. (2011). Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model. Clin. Sci. 121, 489-499.
82. Villanueva, S., Carreño, J. E., Salazar, L., Vergara, C., Strodthoff, R., Fajre, F., Céspedes, C., Sáez, P. J., Irarrázabal, C., Bartolucci, J. et al. (2013). Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure. Clin. Sci. 125, 199-210.
83. Wang, S., Li, Y., Zhao, J., Zhang, J. and Huang, Y. (2013). Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model. Biol. Blood Marrow Transplant. 19, 538-546.
84. Wever, K. E., Menting, T. P., Rovers, M., van der Vliet, J. A., Rongen, G. A., Masereeuw, R., Ritskes-Hoitinga, M., Hooijmans, C. R. and Warlé, M. (2012). Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis. PLoS ONE 7, e32296.
85. Yamaleyeva, L. M., Guimaraes-Souza, N. K., Krane, L. S., Agcaoili, S., Gyabaah, K., Atala, A., Aboushwareb, T. and Yoo, J. J. (2012). Cell therapy with human renal cell cultures containing erythropoietin-positive cells improves chronic kidney injury. Stem Cells Transl. Med. 1, 373-383.
86. Yuen, D. A., Connelly, K. A., Advani, A., Liao, C., Kuliszewski, M. A., Trogadis, J., Thai, K., Advani, S. L., Zhang, Y., Kelly, D. J. et al. (2010). Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism. PLoS ONE 5, e9543.
87. Yuen, D. A., Connelly, K. A., Zhang, Y., Advani, S. L., Thai, K., Kabir, G., Kepecs, D., Spring, C., Smith, C., Batruch, I. et al. (2013). Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis. Stem Cells 31, 2408-2419.
88. Zhang, Y., Yuen, D. A., Advani, A., Thai, K., Advani, S. L., Kepecs, D., Kabir, M. G., Connelly, K. A. and Gilbert, R. E. (2012). Early-outgrowth bone marrow cells attenuate renal injury and dysfunction via an antioxidant effect in a mouse model of type 2 diabetes. Diabetes 61, 2114-2125.
89. Zhang, L., Li, K., Liu, X., Li, D., Luo, C., Fu, B., Cui, S., Zhu, F., Zhao, R. C. and Chen, X. (2013a). Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in rats. Stem Cells Dev. 22, 3074-3086.
90. Zhang, Y., Ye, C., Wang, G., Gao, Y., Tan, K., Zhuo, Z., Liu, Z., Xia, H., Yang, D. and Li, P. (2013b). Kidney-targeted transplantation of mesenchymal stem cells by ultrasound-targeted microbubble destruction promotes kidney repair in diabetic nephropathy rats. BioMed Research International 2013, 526367.
91. Zhou, H., Tian, H.-M., Long, Y., Zhang, X.-X., Zhong, L., Deng, L., Chen, X.-H. and Li, X.-Q. (2009). Mesenchymal stem cells transplantation mildly ameliorates experimental diabetic nephropathy in rats. Chin. Med. J. (Engl.) 122, 2573-2579.
92. Zhu, X.-Y., Urbieta-Caceres, V., Krier, J. D., Textor, S. C., Lerman, A. and Lerman, L. O. (2013). Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms. Stem Cells 31, 117-125.
93. Zoja, C., Garcia, P. B., Rota, C., Conti, S., Gagliardini, E., Corna, D., Zanchi, C., Bigini, P., Benigni, A., Remuzzi, G. et al. (2012). Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy. Am. J. Physiol. 303, F1370-F1381.